Comparative efficacy and acceptability of different antihypertensive drug classes for cardiovascular disease prevention: protocol for a systematic review and network meta-analysis
Introduction Clinical practice guidelines differ in their recommendations on first-line antihypertensive drug classes. No adequately powered randomised controlled trial have assessed all major drug classes against each other, and previous meta-analyses have mainly relied on pairwise meta-analyses fo...
Saved in:
| Main Authors: | Mattias Brunström, Bo Carlberg, Heidi Jussil |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-03-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/3/e044302.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials
by: Mattias Brunström, et al.
Published: (2019-09-01) -
Sex differences in the efficacy of antihypertensive treatment in preventing cardiovascular outcomes and reducing blood pressure: protocol for a systematic review and meta-analysis
by: Karina Gasbarrino, et al.
Published: (2020-03-01) -
Integrated Antihypertensive and Statin Treatment Protocols for Cardiovascular Disease Prevention in Low- and Middle-Income Countries
by: Andrew E. Moran, et al.
Published: (2024-12-01) -
Sex differences in the adherence of antihypertensive drugs: a systematic review with meta-analyses
by: Giuseppe Mancia, et al.
Published: (2020-07-01) -
Antihypertensive strategies for the prevention of secondary stroke: a systematic review and meta-analysis
by: ChunQi Wang, et al.
Published: (2025-01-01)